Companies: 10,795·Total market cap: $144.5T
The Oncology Institute, Inc.

The Oncology Institute, Inc.

TOINASDAQHealthcare● Active
$5.07
+$0.20(+4.11%)
Market Cap$506913303
P/E Ratio
52W High$5.575
52W Low$2.015

The Oncology Institute, Inc. (TOI) Insider Trading

Form 4 buy vs sell counts, ratio, and sentiment — switch this quarter or last 12 months; chart and transactions below.

SEC EDGAR · FMP · TOI · as of Jun 8, 2026

Activity summary

Buy transactions

12

P-Purchase only

Sell transactions

10

12 Months

Buy/Sell ratio

1.20

Buy/Sell (by trades)

Overall sentiment

BULLISH
↑ Buy 55%Active transactions only · RSU vesting excluded45% Sell ↓

The Oncology Institute, Inc. insiders have been net buyers of shares over the past 12 Months, which may signal confidence in the company's outlook.

Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · Buy = P-Purchase only · Sell = S-Sale only

As of Jun 8, 2026

TOI insider buying and selling by quarter

TOI insider selling · TOI insider buying stocks · quarterly insider activity

Total insider buying (incl. awards)Total insider selling
16.3M8.2M0
2025 Q3
2025 Q4
2026 Q1
2026 Q2

Mobile shows last 4Q · Desktop shows full 8Q

Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · last 8 quarters

As of Jun 8, 2026

Active insiders

Most active in past 12 months · TOI ceo insider trading

Showing all insiders · Click a card to filter the transactions table below

Aggregated from reportingName · top 5 by trade count (12M) · no extra API

Recent insider transactions

TOI executive sell shares · TOI board member insider trading · TOI insider trading SEC filing

Showing 74 most recent · Common Stock · Form 4 only

Scroll horizontally to see all columns

Chernett Jorey

10 percent owner

Purchase

Date

Jun 4

Shares

12,000

Price

$4.75

Value

$57K

View Form 4 on SEC.gov

Podnos Yale

Chief Medical Officer

Other

Date

May 21

Shares

1,805

Price

$4.47

Value

$8K

View Form 4 on SEC.gov

Virnich Daniel

CEO

Other

Date

May 21

Shares

23,058

Price

$4.47

Value

$103K

View Form 4 on SEC.gov

Carter Robert Ross

CFO

Other

Date

May 21

Shares

1,604

Price

$4.47

Value

$7K

View Form 4 on SEC.gov

Chernett Jorey

10 percent owner

Purchase

Date

May 20

Shares

33,500

Price

$4.07

Value

$136K

View Form 4 on SEC.gov

Chernett Jorey

10 percent owner

Purchase

Date

May 19

Shares

5,000

Price

$4.05

Value

$20K

View Form 4 on SEC.gov

Chernett Jorey

10 percent owner

Purchase

Date

May 19

Shares

30,000

Price

$4.09

Value

$123K

View Form 4 on SEC.gov

Kaushal Mohit

Director

Sale

Date

Apr 14

Shares

57,286

Price

$3.50

Value

$201K

View Form 4 on SEC.gov

Kaushal Mohit

Director

Sale

Date

Apr 16

Shares

38,433

Price

$3.50

Value

$135K

View Form 4 on SEC.gov

Chernett Jorey

10 percent owner

Purchase

Date

Apr 9

Shares

20,000

Price

$3.10

Value

$62K

View Form 4 on SEC.gov

Langsam Jeffrey

Chief Clinical Officer

Award

Date

Mar 27

Shares

70,270

Price

Value

View Form 4 on SEC.gov

England Kristin

Chief Administrative Officer

Award

Date

Mar 27

Shares

55,743

Price

Value

View Form 4 on SEC.gov

Podnos Yale

Chief Medical Officer

Award

Date

Mar 27

Shares

66,446

Price

Value

View Form 4 on SEC.gov

Podnos Yale

Chief Medical Officer

Other

Date

Mar 27

Shares

16,173

Price

$3.07

Value

$50K

View Form 4 on SEC.gov

Carter Robert Ross

CFO

Award

Date

Mar 27

Shares

202,914

Price

Value

View Form 4 on SEC.gov

Carter Robert Ross

CFO

Other

Date

Mar 27

Shares

20,320

Price

$3.07

Value

$62K

View Form 4 on SEC.gov

Virnich Daniel

CEO

Award

Date

Mar 27

Shares

670,608

Price

Value

View Form 4 on SEC.gov

Virnich Daniel

CEO

Other

Date

Mar 27

Shares

98,534

Price

$3.07

Value

$302K

View Form 4 on SEC.gov

Chernett Jorey

10 percent owner

Purchase

Date

Mar 27

Shares

27,429

Price

$2.96

Value

$81K

View Form 4 on SEC.gov

Chernett Jorey

10 percent owner

Purchase

Date

Mar 26

Shares

50,000

Price

$3.15

Value

$158K

View Form 4 on SEC.gov

Chernett Jorey

10 percent owner

Purchase

Date

Mar 24

Shares

125,000

Price

$3.11

Value

$389K

View Form 4 on SEC.gov

Chernett Jorey

10 percent owner

Purchase

Date

Mar 20

Shares

25,000

Price

$3.35

Value

$84K

View Form 4 on SEC.gov

Virnich Daniel

CEO

Other

Date

Mar 17

Shares

11,834

Price

$3.59

Value

$42K

View Form 4 on SEC.gov

Carter Robert Ross

CFO

Other

Date

Mar 17

Shares

1,314

Price

$3.59

Value

$5K

View Form 4 on SEC.gov

Podnos Yale

Chief Medical Officer

Other

Date

Mar 17

Shares

3,420

Price

$3.59

Value

$12K

View Form 4 on SEC.gov

⚡ = value ≥ $1M · Award/Option price shows — · formType=4 · securityName=Common Stock · url → sec.gov/Archives/edgar

1 / 3

Source: SEC EDGAR · Form 4 filings · ⚡ = value ≥ $1M · Award/Option price shows —

About TOI insider trading

TOI insider trades

The Oncology Institute, Inc. (TOI) insider trading data is sourced from SEC Form 4 filings submitted by corporate insiders, including Chernett Jorey (10 percent owner), Podnos Yale (Chief Medical Officer), Virnich Daniel (CEO). Over the past 12 months, 5 insiders have filed transactions with the SEC. TOI insiders have been primarily buying, which may reflect pre-scheduled Rule 10b5-1 plan executions.

For The Oncology Institute, Inc.'s institutional ownership breakdown and insider ownership percentage, see the Ownership tab → Ownership tab →

Buy/Sell signal logic
acquisitionOrDisposition field:
A = Acquisition (buy) · D = Disposition (sell)
RSU vesting (M-Exempt) excluded from sentiment
Form 4SEC filing required within 2 business days of any insider transaction
10b5-1Pre-scheduled trading plan that allows insiders to sell on autopilot
Open MktDirect purchase or sale on the open market (excludes awards, options)

Frequently asked questions

TOI insider trading · 5 questions

The insiders of The Oncology Institute, Inc. (TOI) include executives and directors such as Chernett Jorey (10 percent owner), Podnos Yale (Chief Medical Officer), Virnich Daniel (CEO), among others. Over the past 12 months, 5 insiders have filed Form 4 transactions with the SEC. Insider transactions are required to be reported within 2 business days of the trade date.

TOI board member insider tradingwho are TOI insidersTOI insider rosterThe Oncology Institute, Inc. executives insider activity

Source: FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · acquisitionOrDisposition A=Buy, D=Sell · RSU vesting (M-Exempt) excluded from sentiment bar · As of Jun 8, 2026